Eli Lilly Discontinues Evacetrapib; Investors Move Bets To Alternatives

By: via Benzinga
Eli Lilly and Co (NYSE: LLY) shares are plunging nearly 8.0 percent in early trading on Monday after the company announced that it is ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.